Related Experiment Video

Updated: Jul 18, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

RNA interference technologies and their use in cancer research

Alex Gaither1, Vadim Iourgenko

  • 1Genome and Proteome Sciences Department, Platform and Chemical Biology Unit, Novartis Institute for Biomedical Research, Cambridge, Massachusetts 02139, USA.

Current Opinion in Oncology
|November 30, 2006
PubMed
Abstract

Insights

RNA interference (RNAi) is a powerful tool for cancer research, enabling functional gene characterization and genomic screening. RNAi-based loss-of-function studies help identify cancer targets and chemoresistance mechanisms.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Tumorigenesis arises from accumulated mutations in genes regulating cell proliferation and death.
  • Identifying effective, non-toxic cancer chemotherapeutics remains a significant research challenge.

Purpose of the Study:

  • To review recent studies utilizing RNA interference (RNAi) reagents for functional gene characterization.
  • To focus on RNAi-based genomic screening for understanding the molecular basis of cancer.
  • To explore RNAi as a tool for validating cancer targets and developing therapeutic strategies.

Main Methods:

  • Utilizing genome-wide RNA interference reagents for loss-of-function studies.
  • Analyzing data from recent studies employing RNA interference in cancer models.
  • Focusing on RNA interference-based genomic screening approaches.

Main Results:

  • Loss-of-function studies can validate known and novel tumor-associated targets.
  • RNA interference-mediated gene knockdown reveals cancer-specific gene interactions and chemoresistance mechanisms.
  • Simultaneous use of cancer drugs and RNA interference offers strategies to inhibit neoplastic growth.

Conclusions:

  • RNA interference is a valuable tool for dissecting cancer biology and identifying therapeutic targets.
  • RNAi facilitates the study of gene circuitry, interactions, and chemoresistance in cancer cells.
  • Combined RNAi and drug therapies present a promising paradigm for cancer treatment development.

More Related Videos

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

DNA Vector-based RNA Interference to Study Gene Function in Cancer13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...